Literature DB >> 2806248

The metabolic consequences of hydroperoxide perfusion on the isolated rat heart.

J C Chatham1, H F Gilbert, G K Radda.   

Abstract

Perfusion of rat hearts with Krebs-Henseleit bicarbonate buffer containing low concentrations of hydrogen peroxide or t-butylhydroperoxide (50-500 microM) caused an imbalance in the relative synthesis versus utilization rates of ATP, leading to a net hydrolysis of ATP and phosphocreatine. Hydrogen peroxide also caused an 80% inactivation of glyceraldehyde-3-phosphate dehydrogenase, resulting in an inhibition of glycolysis and a rapid accumulation of sugar phosphates as detected with 31P-NMR spectroscopy. This inhibition was partially reversible with peroxide-free perfusion, resulting in a cessation of high-energy-phosphate hydrolysis and a decrease in the accumulated inorganic phosphate and sugar phosphate. t-Butylhydroperoxide toxicity was irreversible. Providing an alternative, non-glycolytic substrate (butyrate) did not protect against the toxicity of hydrogen peroxide, but altered the relative importance of sugar phosphate formation versus ATP hydrolysis. Experiments with heart homogenates in vitro suggest that the inhibition of glyceraldehyde-3-phosphate dehydrogenase is a consequence of a direct reaction of the enzyme with hydrogen peroxide or one of its metabolites. Hearts subjected to total global ischemia (10-20 min), followed by reperfusion with oxygenated buffer, showed no detectable inactivation of glyceraldehyde-3-phosphate dehydrogenase, indicating that ischemia and reperfusion do not result in the production of high global concentrations of hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806248     DOI: 10.1111/j.1432-1033.1989.tb15063.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic beta-cells.

Authors:  P Krippeit-Drews; C Kramer; S Welker; F Lang; H P Ammon; G Drews
Journal:  J Physiol       Date:  1999-01-15       Impact factor: 5.182

3.  Role of methylglyoxal in essential hypertension.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

4.  Regulation of the activity of glyceraldehyde 3-phosphate dehydrogenase by glutathione and H2O2.

Authors:  V V Vaidyanathan; P S Sastry; T Ramasarma
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

5.  Mechanism of oxidative stress-induced intracellular acidosis in rat cerebellar astrocytes and C6 glioma cells.

Authors:  K L Tsai; S M Wang; C C Chen; T H Fong; M L Wu
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

6.  Role of high-energy phosphate metabolism in hydrogen peroxide-induced cardiac dysfunction.

Authors:  Y Matsumoto; M Kaneko; M Iimuro; Y Fujise; H Hayashi
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

7.  Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts.

Authors:  M C Corretti; Y Koretsune; H Kusuoka; V P Chacko; J L Zweier; E Marban
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 8.  Antioxidant properties of myocardial fuels.

Authors:  Robert T Mallet; Jie Sun
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

9.  Control of the intracellular redox state by glucose participates in the insulin secretion mechanism.

Authors:  Eduardo Rebelato; Fernando Abdulkader; Rui Curi; Angelo Rafael Carpinelli
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

10.  Myocardial creatine levels do not influence response to acute oxidative stress in isolated perfused heart.

Authors:  Dunja Aksentijević; Sevasti Zervou; Kiterie M E Faller; Debra J McAndrew; Jurgen E Schneider; Stefan Neubauer; Craig A Lygate
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.